Attention investors! The Best of Keiretsu Forum Investment Showcase is here, with the best deal flow that came through 2024. Join us in honoring some of the best early-stage companies of 2024 and explore investment opportunities to close the year with a bang. Register now: https://lnkd.in/dssPm_zY
Keiretsu Capital
风险投资与私募股权管理人
Seattle,WA 2,596 位关注者
Keiretsu Capital's mission is to create funds that leverage its unique network relationships. #FundingtheFuture
关于我们
Keiretsu Capital was established with the express mission of fostering closer ties between Keiretsu Forum angels, the institutional investor community and Keiretsu Forum portfolio companies. Keiretsu Capital provides its investors access to proprietary deal flow by investing alongside the angels, providing additional capital to complete rounds and acting to source follow on capital where appropriate. Keiretsu Capital works to increase the value of investments undertaken by Keiretsu Forum members by assisting in the successful presentation of the portfolio companies to investors including syndicate partners, venture capitalists, corporate investors, and the public markets. Keiretsu Capital aims to provide significant capital appreciation through investment in high quality emerging companies that have been funded by the world’s largest angel investor network, Keiretsu Forum, as well as other top tier angel groups. Comprised of serious investors, accomplished business leaders and serial entrepreneurs, our mission is to accelerate technology company success and pursue the high upside value potential in these dynamic investment opportunities while promoting the sharing of risk inherent in any early stage venture. We recognizes the crucial and active role that experienced angel investors can play in nurturing emerging companies, and draws upon the significant knowledge and expertise of our investors, Keiretsu Forum members and Keiretsu Capital managers to actively guide and support portfolio companies. We seek opportunities in which a strong management team is in place to guide development of the core technology and the organization needed to realize the company’s market potential. Further, we will continue to seek Keiretsu Members that bring geographic diversity to our membership to enhance the probability of identifying investment opportunities and building a broad base of contacts and functional and technical expertise. www.keiretsucapital.com
- 网站
-
https://www.keiretsucapital.com/
Keiretsu Capital的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- Seattle,WA
- 类型
- 合营企业
- 创立
- 2013
- 领域
- Angel Investment、Venture Capital、Co-Investment和Syndication
地点
-
主要
2815 Eastlake Ave East
Suite 300
US,WA,Seattle,98102
Keiretsu Capital员工
动态
-
#KeiretsuBacked Healionics Corporation has earned FDA Breakthrough Device designation for its STARgraft arteriovenous graft, offering significant advancements in dialysis access. The milestone accelerates regulatory approval and enhances access for kidney failure patients. Congratulations to the Healionics team! Learn more: https://lnkd.in/daZ-2TTy
-
#KeiretsuBacked Cascadia Seaweed has been named to Foresight Canada’s 2024 #Foresight50 list, recognizing Canada’s most investible cleantech ventures! This milestone highlights Cascadia Seaweed’s commitment to driving sustainable solutions and advancing the transition to a net-zero economy. With this recognition, Cascadia Seaweed solidifies its position as a leader in the cleantech industry, setting the pace for innovation and impact in sustainable growth. Learn more: https://lnkd.in/duhzJFs7
-
#KeiretsuBacked KEY.co has partnered with Capital One Travel to offer Venture and Spark Miles cardholders exclusive access to luxury vacation rentals. With a curated selection of exceptional properties and personalized in-home services, KEY.co creates unforgettable travel experiences, from beachfront villas to chic urban retreats. This collaboration sets KEY.co apart, leading the way in redefining luxury vacation rentals. Learn more: https://lnkd.in/g4mF3yPi
-
#KeiretsuBacked LumiThera, Inc. achieves a major breakthrough with FDA authorization of its Valeda? Light Delivery System—the first approved treatment for vision loss in dry AMD patients! Valeda’s non-invasive therapy offers new hope, showing significant vision improvement in the LIGHTSITE III trial. Congratulations, LumiThera, for pioneering advancements in eye care! Learn more: https://lnkd.in/dwuzBV8t
-
#KeiretsuBacked Spinal Simplicity has been awarded the 2024 Best Technology in Spine Award by Orthopedics This Week for its innovative Liberty SI? Lateral SI system! This recognition, granted by a panel of leading spine and neurosurgeons, highlights Spinal Simplicity’s dedication to advancing minimally invasive solutions for sacroiliac (SI) joint dysfunction. We’re thrilled to support their mission to improve patient outcomes and revolutionize spine care. Congratulations to the Spinal Simplicity team on this well-deserved honor! Read more: https://lnkd.in/dfDdVZpj #SpinalSimplicity #SpineInnovation #MedicalInnovation #HealthcareTransformation
-
#KeiretsuBacked NuvOx Pharma continues to make groundbreaking strides in cancer treatment! Co-Founders Dr. Evan Unger and Dr. Jennifer LH Johnson recently published studies on their innovative drug candidate, NanO2?, exploring its oxygen delivery mechanism and a Phase 2b trial for aggressive brain cancer. This research solidifies NuvOx’s leadership in advancing cancer therapies. Learn more: https://lnkd.in/duBQd84V #NuvOx #CancerResearch #CancerTreatment #Healthcare
-
#KeiretsuBacked EarthGrid PBC achieves another major milestone, raising $14M in its latest funding round and oversubscribing by 30%! This success underscores strong investor confidence in EarthGrid's vision to revolutionize infrastructure with its plasma-powered boring systems. Learn more: https://lnkd.in/d5qxkGBG #KeiretsuBacked #EarthGrid #FundingSuccess #InfrastructureInnovation #AngelInvesting
-
#KeiretsuBacked Pattern Computer is set to present at BIO-Europe 2024! Chair and CEO Mark Anderson will showcase breakthroughs in drug discovery through “Project StarBright,” and the ProSpectral? diagnostics platform, targeting the world’s top five cancers. Don't miss their presentation on November 4th in Stockholm! Read more: https://lnkd.in/dQdXD8Mq #PatternComputer #ProSpectral #DrugDiscovery #PrecisionMedicine #CancerDiagnostics
-
#KeiretsuBacked Yellow Card App has raised $33M in new funding, fueling its mission to revolutionize cross-border payments across Africa. As a fintech leader in 20 countries, Yellow Card is transforming the financial landscape with crypto, offering affordable money transfers where traditional banking falls short. Expansion plans include Ethiopia, Egypt, and Morocco! Read more: https://lnkd.in/dNTZhFn4 #YellowCard #FintechInnovation #CryptoPayments #Fintech